SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001562180-23-005445
Filing Date
2023-06-22
Accepted
2023-06-22 09:16:51
Documents
1
Period of Report
2023-06-20

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primarydocument.html 4  
1 PRIMARY DOCUMENT primarydocument.xml 4 4035
  Complete submission text file 0001562180-23-005445.txt   5652
Mailing Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472
Business Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472 617-926-5000
EyePoint Pharmaceuticals, Inc. (Issuer) CIK: 0001314102 (see all company filings)

IRS No.: 262774444 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 3826 Laboratory Analytical Instruments
Industrial Applications and Services

Mailing Address C/O EYEPOINT PHARMACEUTICALS, INC. 480 PLEASANT STREET, SUITE A-210 WATERTOWN MA 02472
Business Address
Pine Michael Craig (Reporting) CIK: 0001904458 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-51122 | Film No.: 231031631